Tema Neuroscience and Mental Health ETF (MNTL) Holdings $23.81 +0.01 (+0.04%) Closing price 08/6/2025Extended Trading$23.81 0.00 (0.00%) As of 08/6/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 25 MNTL HoldingsRankCompanyCurrent PriceWeightShares Held1VRTXVertex Pharmaceuticals$392.05+0.8%10.36%2,2982REGNRegeneron Pharmaceuticals$579.61-1.3%8.12%1,4883ALNYAlnylam Pharmaceuticals$452.33-0.4%7.94%1,9824ARGXargenex$704.07-0.5%5.87%8905NBIXNeurocrine Biosciences$138.94+0.6%4.77%3,9046TEVATeva Pharmaceutical Industries$18.03-0.1%4.32%28,8617LLYEli Lilly and Company$732.25-0.3%4.02%5478CRNXCrinetics Pharmaceuticals$30.65+0.8%3.52%13,0669IONSIonis Pharmaceuticals$42.62-0.3%3.45%8,31810SYKStryker$389.73-0.9%3.19%877 Get the Latest News and Ratings for MNTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. 11BIIBBiogen$132.65-2.7%3.16%2,50112MDTMedtronic$91.97-0.1%2.55%2,97613ACADACADIA Pharmaceuticals$26.23-1.3%2.43%10,59614UCB SAN/A2.43%1,19315AXSMAxsome Therapeutics$121.75-0.1%2.37%2,32716CPRXCatalyst Pharmaceuticals$20.38+0.9%2.36%11,35217DNLIDenali Therapeutics$15.65+0.3%2.09%15,17418XENEXenon Pharmaceuticals$38.60-0.7%1.94%6,11119RNAAvidity Biosciences$48.58+1.6%1.92%5,39220US DOLLARSN/A1.92%201,17421JAZZJazz Pharmaceuticals$126.13+1.4%1.85%1,67222SRRKScholar Rock$33.28-3.5%1.71%4,83623DXCMDexCom$75.08-1.7%1.62%2,23124PTCTPTC Therapeutics$49.79+0.0%1.56%3,12425ALKSAlkermes$28.93-1.1%1.51%5,940 Related Companies and Tools Related Companies FINE Holdings USRD Holdings BOTT Holdings BULD Holdings WNDY Holdings SPAM Holdings TEKX Holdings PTEC Holdings ARVR Holdings XDNA Holdings This page (NASDAQ:MNTL) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access